Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Partheen, Karolina"'
Publikováno v:
In Gynecologic Oncology October 2013 131(1):52-58
Autor:
Österberg, Lovisa, Åkeson, Margaretha, Levan, Kristina, Partheen, Karolina, Zetterqvist, Britt-Marie, Brännström, Mats, Horvath, György
Publikováno v:
In Cancer Genetics and Cytogenetics 2006 167(2):103-108
Publikováno v:
In Cancer Genetics and Cytogenetics 2005 163(2):144-150
Autor:
Kristjansdottir Björg, Partheen Karolina, Fung Eric T, Marcickiewicz Janusz, Yip Christine, Brännström Mats, Sundfeldt Karin
Publikováno v:
Clinical Proteomics, Vol 9, Iss 1, p 14 (2012)
Abstract Background We aimed to investigate the use of ovarian cyst fluid as a source for biomarker discovery and to find novel biomarkers for use in the diagnosis of epithelial ovarian tumors. Results Ovarian cyst fluids from 218 women were collecte
Externí odkaz:
https://doaj.org/article/f0eb3e70047644598da04282d7bace9a
Autor:
Samuelson Emma, Karlsson Sara, Partheen Karolina, Nilsson Staffan, Szpirer Claude, Behboudi Afrouz
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 352 (2012)
Abstract Background Development of breast cancer is a multistage process influenced by hormonal and environmental factors as well as by genetic background. The search for genes underlying this malignancy has recently been highly productive, but the e
Externí odkaz:
https://doaj.org/article/50cea71cce7246869b583255967c7009
Autor:
Olsson Björn, Delle Ulla, Partheen Karolina, Levan Kristina, Österberg Lovisa, Sundfeldt Karin, Horvath György
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 368 (2009)
Abstract Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive markers of chemoresponse would help to individualize therapy and improve survival of ovarian cancer patients.
Externí odkaz:
https://doaj.org/article/c2496e639d82495ea8d1d7a4d5116cca
Autor:
Sundfeldt Karin, Claesson Ingela, Österberg Lovisa, Levan Kristina, Partheen Karolina, Horvath György
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 336 (2009)
Abstract Background The majority of women with ovarian cancer are diagnosed in late stages, and the mortality rate is high. The use of biomarkers as prognostic factors may improve the treatment and clinical outcome of these patients. We performed an
Externí odkaz:
https://doaj.org/article/c4b3ded2a2744ea7a27a5ba866de42b2
Autor:
Kristjánsdóttir, Björg1, Partheen, Karolina1, Fung, Eric T.2, Yip, Christine2, Levan, Kristina1, Sundfeldt, Karin1
Publikováno v:
Cancer Medicine. Oct2014, Vol. 3 Issue 5, p1302-1312. 11p.
Publikováno v:
Journal of Gynecologic Oncology. Dec2011, Vol. 22 Issue 4, p244-252. 9p.
Autor:
Österberg, Lovisa, Levan, Kristina, Partheen, Karolina, Delle, Ulla, Olsson, Björn, Horvath, Karin
Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive markers of chemoresponse would help to individualize therapy and improve survival of ovarian cancer patients. Chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c48413bcb3be7c6ab38b011c6615b8b5
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-3647
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-3647